Moses Rodriguez

USPTO Granted Patents = 25 (Patent Applications = 14)

CIPO Patents = 5 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 8)

Average Co-Inventor Count = 2.7

ph-index = 9

Forward Citations = 211(Granted Patents)

Company Filing History:

24 out of 1,746

Mayo Foundation for Medical Education and Research

patents

3 out of 90

Acorda Therapeutics, Inc.

patents

1 out of 204

University of Vermont and State Agricultural College

patents

4. 1 out of 796

Florida State University Research Foundation, Inc.

patents

5. 1 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2024

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12037590 - Short DNA aptamers and methods for promoting remyelination (2024-07-16),

2. 11274131 - IgM-mediated receptor clustering and cell modulation (2022-03-15),

3. 11180543 - Treatment of neonatal hypoxia including impairments or effects thereof (2021-11-23),

4. 10351620 - Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system (2019-07-16),

5. 10202430 - IgM-mediated receptor clustering and cell modulation (2019-02-12),

6. 9981019 - Methods and materials for reducing the severity of viral infections (2018-05-29),

7. 9809823 - DNA aptamers for promoting remyelination (2017-11-07),

8. 9751943 - Compositions and methods including a recombinant human MAB that promotes CNS remyelination (2017-09-05),

9. 9701745 - Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system (2017-07-11),

10. 9481887 - DNA aptamers for promoting remyelination (2016-11-01),

11. 9421242 - Methods and materials for reducing the severity of viral infections (2016-08-23),

12. 9260512 - Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system (2016-02-16),

13. 9150867 - DNA aptamers for promoting remyelination (2015-10-06),

14. 8968735 - Compositions and methods including a recombinant human MAB that promotes CNS remyelination (2015-03-03),

15. 8460665 - Compositions and methods including a recombinant human MAB that promotes CNS remyelination (2013-06-11),

Title: Moses Rodriguez: Innovator in DNA Aptamers and Cellular Modulation

Introduction

Moses Rodriguez, a prominent inventor based in Rochester, MN, has made significant contributions to the field of biotechnology. With an impressive portfolio of 25 patents, his innovations focus primarily on leveraging DNA aptamers and multivalent molecules to treat demyelinating diseases and modulate cellular functions.

Latest Patents

Rodriguez's latest patents include groundbreaking methods for promoting remyelination through short DNA aptamers. These materials and methods provide innovative solutions for treating demyelinating diseases, showing promise in enhancing recovery of nerve fibers. Another notable patent focuses on IgM-mediated receptor clustering and cell modulation. This patent outlines materials and methods for using multivalent molecules, such as antibodies, to modulate cellular functions. Specifically, it details how these molecules can be targeted to specific cell types, either by direct binding to an epitope on the cell surface or through a linker recognizing both the multivalent molecule and a cellular marker.

Career Highlights

Moses has had an impressive career trajectory, working with organizations renowned for their contributions to medical research and innovation. He has held positions at the Mayo Foundation for Medical Education and Research and Acorda Therapeutics, Inc., where he has made substantial strides in his field, further solidifying his reputation as an expert innovator.

Collaborations

Throughout his career, Rodriguez has collaborated closely with renowned colleagues, including Larry R Pease and David J Miller. These partnerships have allowed for the amalgamation of ideas, leading to enhanced research outcomes and the development of transformative patents.

Conclusion

Moses Rodriguez stands out as a leading figure in the realm of biotechnology inventions. His 25 patents demonstrate not only his creativity and expertise but also his commitment to advancing health through innovative scientific solutions. As the potential impacts of his latest work on remyelination and cellular modulation unfold, the scientific community eagerly anticipates the future contributions of this remarkable inventor.

This text is generated by artificial intelligence and may not be accurate.